Cargando…
Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006270/ https://www.ncbi.nlm.nih.gov/pubmed/35404433 http://dx.doi.org/10.1182/bloodadvances.2021006915 |
| _version_ | 1784686630499516416 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9006270 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90062702022-04-13 Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. Blood Adv Errata American Society of Hematology 2022-04-11 /pmc/articles/PMC9006270/ /pubmed/35404433 http://dx.doi.org/10.1182/bloodadvances.2021006915 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Errata Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title | Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title_full | Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title_fullStr | Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title_full_unstemmed | Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title_short | Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092. |
| title_sort | völker la, kaufeld j, miesbach w, et al. real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. blood adv. 2020;4(13):3085-3092. |
| topic | Errata |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006270/ https://www.ncbi.nlm.nih.gov/pubmed/35404433 http://dx.doi.org/10.1182/bloodadvances.2021006915 |